---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-044715"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:21:53.449963+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Bionano Genomics raises ~$3M in registered direct offering of 9.9M shares and warrants at $0.3039/unit

## Summary
- Issued 9,881,113 shares of common stock and Series C/D warrants to purchase up to 9,881,113 shares each at $0.3039 per share.
- Gross proceeds of $3M from offering, with potential additional $6M if warrants fully exercised on cash basis.
- Closing expected on October 31, 2024; H.C. Wainwright acted as exclusive placement agent with 6% cash fee.
- Net proceeds to be used for working capital, R&D, repayment or redemption of existing indebtedness, and capex.
- Warrants exercisable only after stockholder approval; Series C expires in 5 years, Series D in 18 months.

## SEC filing metadata
- accession: 0001140361-24-044715
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000114036124044715/0001140361-24-044715-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000114036124044715/ny20037830x2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-044715
- JSON: https://secwatch.observer/filing/0001140361-24-044715.json
- Plain text: https://secwatch.observer/filing/0001140361-24-044715.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.